Table 1 Clinical and demographic characteristics of the CML patients
Characteristics | No. of patients (%) |
|---|---|
Total | 46 (100%) |
Gender | |
Female | 24 (52.2%) |
Male | 22 (47.8%) |
Age | |
Average | 45.2 years |
Range | 18–69 years |
Phase | |
Chronic | 29 (63%) |
Accelerated | 8 (17.4%) |
Blastic | 9 (19.6%) |
Sokal Index | |
A | 11 (23.9%) |
B | 13 (28.3%) |
C | 19 (41.3%) |
N/A | 3 (6.5%) |
Response to kinase inhibitor therapy | |
Sensitive | 17 (37%) |
Resistant | 22 (47.8%) |
N/A | 7 (15.2%) |